Open AccessThis article is
- freely available
Herpes Virus Amplicon Vectors
Department of Biochemistry and Biophysics, University of Rochester, Rochester, NY 14642, USA
Center for Neural Development and Disease, University of Rochester, Rochester, NY 14642, USA
School of Medicine and Dentistry, University of Rochester, Rochester, NY 14642, USA
Department of Neurology, University of Rochester, Rochester, NY 14642, USA
Department of Microbiology and Immunology, University of Rochester, Rochester, NY 14642, USA
* Author to whom correspondence should be addressed.
Received: 30 September 2009; in revised form: 26 October 2009 / Accepted: 29 October 2009 / Published: 29 October 2009
Abstract: Since its emergence onto the gene therapy scene nearly 25 years ago, the replication-defective Herpes Simplex Virus Type-1 (HSV-1) amplicon has gained significance as a versatile gene transfer platform due to its extensive transgene capacity, widespread cellular tropism, minimal immunogenicity, and its amenability to genetic manipulation. Herein, we detail the recent advances made with respect to the design of the HSV amplicon, its numerous in vitro and in vivo applications, and the current impediments this virus-based gene transfer platform faces as it navigates a challenging path towards future clinical testing.
Keywords: herpes simplex virus; HSV amplicon; gene transfer; immunotherapy; integration
Citations to this Article
Cite This Article
MDPI and ACS Style
De Silva, S.; Bowers, W.J. Herpes Virus Amplicon Vectors. Viruses 2009, 1, 594-629.
De Silva S, Bowers WJ. Herpes Virus Amplicon Vectors. Viruses. 2009; 1(3):594-629.
De Silva, Suresh; Bowers, William J. 2009. "Herpes Virus Amplicon Vectors." Viruses 1, no. 3: 594-629.